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Background. The 12/15-lipoxygenase (12/15-LO) enzyme
has been implicated in the pathogenesis of diabetic nephropa-
thy since lipoxygenase products induce cellular hypertrophy
and extracellular matrix deposition in mesangial cells. In this
study, in order to determine the potential in vivo functional
role of 12/15-LO in kidney disease, we compared mouse mesan-
gial cells (MMCs) derived from 12/15-LO knockout mice with
those from genetic control wild-type mice.
Methods. MMCs were isolated from wild-type and 12/15-
LO knockout mice. Cellular growth, activation of mitogen-
activated protein kinases (MAPKs), transcription factors, su-
peroxide levels, and fibronectin expression were compared in
the two cell types.
Results. Levels of the 12/15-LO product and protein were
lower in MMC from 12/15-LO knockout relative to wild-type.
MMCs from 12/15-LO knockout mice grew slower than wild-
type cells, and also showed lower rates of tritiated thymidine
and leucine incorporation (21% and 15% of wild-type, respec-
tively, P  0.001). Levels of superoxide and the matrix protein
fibronectin were also lower in 12/15-LO knockout mice cells.
Serum and angiotensin II (Ang II)-stimulated activities of p38
or ERK1/2 MAPKs, and cyclic adenosine monophosphate
(cAMP)-responsive element binding protein (CREB) tran-
scription factor were lower in 12/15-LO knockout relative to
wild-type cells. In addition, DNA binding and transcriptional
activities of activated protein-1 (AP-1) and CREB were lower
in 12/15-LO knockout cells. Furthermore, stable 12/15-LO over-
expression in MMC led to reciprocal increase in p38 MAPK
activation and fibronectin expression.
Conclusion. The differential activation of oxidant stress,
specific signaling pathways, transcription factors, and growth
1See Editorial by Kasinath, p. 1918.
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and matrix genes may lead to reduced growth and growth factor
responses in 12/15-LO knockout versus wild-type MMCs. These
results provide ex vivo functional evidence for the first time
that 12/15-LO activation plays a key role in mesangial cell
responses associated with renal diseases such as diabetic ne-
phropathy.
Diabetic nephropathy is characterized by the thick-
ening of glomerular basement membranes, increased cel-
lular hypertrophy and deposition of extracellular matrix
in mesangial areas [1, 2]. Studies indicate that these renal
pathologies can be mediated by the action of hyperglyce-
mia, advanced glycation end products, oxidant stress,
several growth factors such as angiotensin II (Ang II),
platelet-derived growth factor (PDGF), and transforming
growth factor-beta (TGF-) [3–8]. However, the molecu-
lar and cellular mechanisms involved in the pathogenesis
of diabetic nephropathy are not very clear.
Lipoxygenases (LO) are a family of nonheme iron-
containing enzymes that insert molecular oxygen into
polyunsaturated fatty acids such as arachidonic and lino-
leic acids [9, 10]. They are classified as 5-, 8-, 12-, and
15-LOs according to the carbon atom of arachidonic acid
at which the oxygen is inserted. 12-LO activation can
lead to the formation of oxidized lipids such as 12(S)-
hydroxyeicosatetraenoic acid [12(S)-HETE] [9, 10]. Three
major isoforms of 12-LO are platelet-type 12-LO, macro-
phage- or leukocyte-type 12-LO (12/15-LO), and epider-
mal-type 12-LO [9–11]. Human and rabbit 15-LOs as
well as the leukocyte-type 12-LO have high homology
and are classified as 12/15-LO since they can form both
12(S)-HETE and 15(S)-HETE from arachidonic acid
and mainly 13(S)-hydroperoxyoctadecadienoic acid from
linoleic acid [9–11]. The presence of leukocyte-type
12/15-LO has been demonstrated in various cells and
tissues, including adrenal cells, vascular smooth muscle
cells (VSMC), brain, and kidney [4, 12–16]. In mice, both
leukocyte 12/15-LO as well as platelet 12-LO are ex-
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pressed [17]. A leukocyte-type 12/15-LO has been identi-
fied and partially sequenced from rat glomeruli [15].
Evidence shows that 12/15-LO and their products of
arachidonic acid metabolism such as 12(S)-HETE can
mediate growth factor effects in cells such as VSMC
and fibroblasts, as well as responses to vascular injury
[18–23]. One study reported that urinary excretion of
12(S)-HETE was increased in diabetic patients as com-
pared with control subjects [24]. Although the presence
of 12/15-LO has been recognized in the kidney [4, 15],
much less is known regarding the functional effects or
the in vivo significance. We recently showed that 12/15-
LO mRNA and protein are increased in glucose-stimu-
lated mesangial cells and in experimental diabetic ne-
phropathy [4]. Furthermore, the in vivo expression of
the matrix protein fibronectin and TGF- in the diabetic
rat glomeruli was associated with increased glomerular
12/15-LO expression [4] thereby implicating the 12/15-
LO pathway in the pathogenesis of diabetic nephropa-
thy. Factors relevant to the pathogenesis of diabetic ne-
phropathy such as high glucose, Ang II and PDGF can
induce leukocyte-type 12/15-LO activity and expression
in VSMC and in rat mesangial cells [4, 16, 19, 25]. The
growth-promoting and matrix-inducing effects of Ang II
in mesangial cells were blocked by pharmacologic 12-LO
inhibitors as well as a novel 12-LO ribozyme [25]. Fur-
thermore, 12(S)-HETE could directly induce cellular hy-
pertrophy and expression of the extracellular matrix pro-
tein, fibronectin in rat mesangial cells and VSMC with
similar potency as Ang II [18, 20, 25]. 12(S)-HETE-
induced effects were mediated at least in part by activa-
tion of the p38 mitogen-activated protein kinase (p38
MAPK) and its target transcription factor, cyclic adeno-
sine monophosphate (AMP) response element binding
protein (CREB), which is related to matrix gene expres-
sion [20, 25]. A similar observation was recently made
in adrenocortical cells [26].
Sun and Funk [27] have created mice that are deficient
in leukocyte (macrophage) 12/15-LO. Cross-breeding
studies showed that these mice could reduce the rates of
atherosclerosis in the susceptible low density lipoprotein
(LDL) receptor knockout as well as apolipoprotein E
(Apo E) knockout mice [28–30]. This appeared to be due
to reduced rates of macrophage LDL oxidation [30, 31].
Furthermore, these 12/15-LO knockout mice were resis-
tant to the development of diabetes in response to low-
dose streptozotocin [32]. While these results have estab-
lished an in vivo role for 12/15-LO in the pathogenesis
of atherosclerosis and islet dysfunction associated with
type 1 diabetes, its in vivo role in the development of
renal diseases such as diabetic nephropathy is not yet
known. In the present study, in order to determine the
potential in vivo functional role of 12/15-LO in mesangial
cell growth related to kidney diseases such as glomerulo-
sclerosis and nephropathy, and also to identify the molec-
ular mechanisms involved, we compared the properties
of mouse mesangial cells (MMCs) derived from 12/15-
LO knockout mice with those obtained from genetic
control wild-type mice ex vivo. We observed that cellular
growth, matrix production, activation of oxidant stress,
specific signaling pathways, and transcription factors
were attenuated in the 12/15-LO knockout cells relative
to wild-type cells. In addition, we also noted that stable
overexpression of mouse 12/15-LO in a MMC cell line
led to reciprocal increase in MAPK activation and fi-
bronectin expression. Our results suggest that 12/15-LO
activation can play a key role in mediating mesangial
cell growth and matrix responses associated with the
development of renal disease, particularly that associ-
ated with diabetes.
METHODS
Histologic evaluation of sections from wild-type and
12/15-LO knockout mouse kidney cortices
All animal studies were performed according to the
guidelines of the National Institutes of Health and with
an approved protocol from the City of Hope Research
Animal Care Committee. Genetic control (wild-type,
C57BL/6) and leukocyte 12/15-LO knockout mice on a
C57BL/6 background (Strain name, B6.129S2-Alox15t-
m1Fun, Stock Number 002778) were obtained from Jack-
son Laboratories (Bar Harbor, ME, USA). Renal corti-
ces from the kidneys of 8- to 10- week-old wild-type and
12/15-LO knockout mice were incubated overnight at
4C in 4% paraformaldehyde and then embedded in
paraffin. Paraffin-embedded sections from the two mice
were evaluated by hematoxylin-eosin staining by stan-
dard methods.
Isolation and characterization of murine mesangial
cells (MMCs)
Kidneys from eight-to ten-week-old male wild-type
and 12/15-LO knockout mice were removed using sterile
techniques. After washing in RPMI 1640 medium, the
cortices were separated from medullas, pooled, minced,
and the glomeruli isolated by differential sieving using
standard methods [4, 33, 34]. Glomeruli were then
treated with collagenase (Sigma Chemical Co., Inc., St.
Louis, MO, USA) for 15 minutes, plated in T-25 culture
flasks (Nunc, Rochester, NY, USA) in RPMI 1640 me-
dium containing 15% fetal calf serum (FCS) (Omega
Scientific, Co., Tarzana, CA, USA) and 20 ug/mL insulin
(Sigma Chemical Co.) and then cultured at 37C with
5% CO2. Outgrowths of spindle-like mesangial cells were
seen after 7 to 10 days. Cells were grown for a further
48 hours in the presence of 50 mmol/L d-valine, replacing
l-valine in the RPMI 1640 to exclude fibroblast growth.
After 48 hours, l-valine-containing normal medium was
replaced. For characterization of the mesangial pheno-
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type, the MMCs were grown on glass chamber slides,
fixed and stained with monoclonal Thy1.1 antibody. Cells
between 5 to 12 passages were used for all studies.
12(S)-HETE assay
Serum-depleted cells were lysed, deacetylated, and ex-
tracted as described earlier [16]. 12(S)-HETE levels in
the extracts were determined using a specific radioimmu-
noassay described earlier [16]. This assay is specific for
12(S)-HETE and does not cross-react with the stereoiso-
mer 12(R)-HETE.
Growth curves
Wild-type and 12/15-LO knockout MMCs were plated
at 5000 cells per dish in 60 mm culture dishes in growth
medium containing 10% FCS. Cell numbers were noted
daily on a Coulter counter (Coulter Z Series, Beckman
Coulter, Fullerton, CA, USA) after trypsinization.
Superoxide measurement by confocal microscopy
MMCs cultured on chamber slides were serum-
depleted and treated with agonists for 30 minutes. They
were then washed with phosphate-buffered saline (PBS)
and incubated with the superoxide probe dihydroethid-
ium (DHE) 10 umol/L (Molecular Probes, Inc., Eugene,
OR, USA) at 37C for 10minutes. After incubation, cells
were washed to remove extracellular dye and imaged
with a laser confocal microscope (excitation 488 nm/
emission 514 nm). The generation of superoxide is indi-
cated by the appearance of red fluorescence. All images
were collected using a 512  512 pixel format and ar-
chived for subsequent analysis to determine relative fluo-
rescence intensity as described [35].
Immunoblot analysis
Cells were lysed as described earlier [25] and the ly-
sates fractionated on 10% sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) gels (Bio-
Rad Laboratories, Hercules, CA, USA). Protein bands
were transferred to nitrocellulose in 25 mmol/L Tris-
HCl, 192 mmol/L glycine, and 10% methanol for 11⁄2
hours at constant current of 100 mA. Membranes were
incubated in 20 mmol/L Tris-HCl, pH 7.6, 137 mmol/L
NaCl, 0.2% vol/vol Tween 20 with 5% wt/vol nonfat
milk at room temperature and incubated overnight at
4C with antibodies to either 12/15-LO [4, 19], phospho-
specific MAPKs, total MAPKs, phospho- and total CREB
(Cell Signaling, Beverly, MA, USA), or cellular fibro-
nectin (EDA sequence) (Chemicon, Temecula, CA, USA).
After further washing in Tris/NaCl/Tween 20, membranes
were incubated for 1 hour with horseradish-linked sec-
ondary antibody, and immunoreactive proteins detected
by Supersignal chemiluminescence reagent (Pierce, Rock-
ford, IL, USA). Immunoblots were scanned using GS-800
densitometer and protein bands quantified with Quanti-
tation One software (Bio-Rad Laboratories).
Incorporation of [3H]-thymidine and [3H]-leucine
Serum-depleted MMCs were incubated for 24 hours
with [3H]-thymidine or [3H]-leucine and Ang II or FCS
at the indicated concentrations. Radioactivity in trichlo-
roacetic acid–insoluble protein precipitates from cells
was determined as described earlier [25].
RNA isolation and reverse transcription-polymerase
chain reaction (RT-PCR)
After stimulation with Ang II or FCS at the indicated
concentrations, total RNA was extracted and relative
multiplex RT-PCRs were performed using18S RNA as
internal control in each sample as described earlier [25].
After normalization to 18S RNA, the results were ex-
pressed as fold expression over control unstimulated
cells. Mouse fibronectin mRNA was amplified using pri-
mers, 5-GCACAACAGACCACCAAACTCG-3 (for-
ward) and 5-CTGAAGTCACTTCTCGGGGTGC-3
(reverse). Primers for c-fos and 18S RNA were from
Ambion Inc. (Austin, TX, USA).
Fibronectin expression by immunofluorescence
Confluent MMCs on glass slides were fixed with 2%
paraformaldehyde in PBS for 15 minutes. Cells were per-
meabilized with 0.2% Triton-X 100 in PBS and washed.
To reduce nonspecific binding, cells were treated with
5% goat serum in PBS and incubated with fibronectin
antibody (1:40), followed by incubation with rhodamine-
conjugated secondary antibody (1:200) and viewed by
fluorescence microscopy. Cells were also stained with
the Hoechst 33342 (Molecular Probes, Inc.) to detect
nuclei.
Preparation of nuclear extracts and electrophoretic
mobility shift assays (EMSA)
Nuclear extracts were prepared as described pre-
viously [20]. Briefly, after serum depletion, MMCs were
stimulated with Ang II (0.1 umol/L) or 10% FCS, washed
with cold PBS (pH 7.6), scraped into 1 mL PBS, and spun
down at 4C. Cell pellets were resuspended in nuclear
extraction buffer A (NEA), 10 mmol/L HEPES, pH 7.9,
1.5 mmol/L MgCl2, 10 mmol/L KCl, and protease inhibi-
tors and then lysed in NEA containing 0.1% NP-40. Cell
lysates were centrifuged and nuclei resuspended in NEC
[10 mmol/L HEPES, pH 7.9, 0.42 mol/L NaCl, 1 mmol/L
ethylenediaminetetraacetic acid (EDTA), 0.5 mmol/L
dithiothreitol (DTT), 25% glycerol, and protease inhibi-
tors). After 30 minutes’ incubation on ice, they were
centrifuged at 4C for 15 minutes and supernatants used
as nuclear extracts. DNA binding of nuclear proteins
was performed as described earlier [20, 25, 36]. Labeled
synthetic oligonucleotides containing consensus-binding
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sequences for transcription factors CREB or activator
protein-1 (AP-1) were used as probes for EMSA. As con-
trol for DNA binding, we used oligonucleotides contain-
ing consensus-binding sequences for the transcription
factor SP-1. Gels were dried, protein-DNA complexes
visualized on a phosphorimager, and the radioactivity of
complexes quantitated using Imagequant software (Mo-
lecular Dynamics, Sunnyvale, CA, USA).
Transient transfections and reporter gene assays
MMCs from both wild type and 12/15-LO knockout
mice were plated at a density of 1  104 cells per well
in 24-well dishes. Next day, they were transiently trans-
fected with either pAP-1-Luc (100 ng/well) or pCRE-
Luc (200 ng/well) (Stratagene, La Jolla, CA, USA) using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA)
according to manufacturer’s instructions. Cells were al-
lowed to recover overnight and then transferred to serum
depletion medium [RPMI-1640 containing 0.2% bovine
serum albumin (BSA)]. Next day, they were stimulated
with FCS (10%) for 6 hours and luciferase activities in
the cell lysates assayed as described previously [20].
Stable transfection of a MMC cell line with
mouse 12/15-LO
Stable mouse 12/15-LO overexpression was performed
in an immortalized MMC cell line [34, 37] (a generous
gift from Dr. K. Sharma, Thomas Jefferson University,
Philadelphia, PA, USA). The MMC cell line was cultured
in Dulbecco’s modified Eagle’s medium (DMEM) with
10% FCS containing 20 mmol/L HEPES, pH 7.4, 10
mmol/L glucose, penicillin, and streptomycin at 37C in
5% CO2 and 95% air. To generate mouse leukocyte type
12/15-LO overexpressing cells, MMCs were plated at a
density of 3  106 cells in a 60 mm dish. The cells were
then transfected with either mouse leukocyte 12/15-LO
cDNA in pcDNA3.1 vector (generous gift from Dr. Colin
Funk, University of Pennsylvania, Philadelphia, PA) or
control pcDNA3.1 vector (Invitrogen) using Lipofec-
tamine 2000 reagent according to manufacturer’s instruc-
tions. The empty control vector pcDNA 3.1 without the
insert was used as the mock-transfected control. After
48 hours, the transfected cells were split 1:10 in 100 mm
dishes in medium containing selection agent G418 (400
ug/mL). This medium was changed every 3 days until
G418-resistant colonies appeared. Individual resistant
clones were isolated 2 to 3 weeks later and expanded
into cell lines. Clones were checked for 12/15-LO over-
expression by Western blotting and 12(S)-HETE levels.
Stable transfectants were maintained in complete medium
containing 10% FCS and 400 ug/mL G418.
Data analyses
Data are expressed as mean SEM of multiple experi-
ments. Paired Student t tests were used to compare two
Fig. 1. Renal glomeruli from wild-type (WT) and 12/15-lipoxygenase
knockout (LOKO) mice. Glomeruli from 8- to 10-week-old male WT
(A) and 12/15-LO knockout mice (B) mice showing similar morphology.
Hematoxylin-eosin stain. Magnification 400.
groups, or analysis of variance (ANOVA) with Dunnett
post test for multiple groups using PRISM software
(Graph Pad, San Diego, CA, USA). Statistical signifi-
cance was detected at the 0.05 level.
RESULTS
Morphology of glomerular sections from wild-type
and 12/15-LO knockout mice
Hematoxylin-eosin staining of renal cortical sections
from wild-type and 12/15-LO knockout mice are seen in
Figure 1. They indicate that the glomeruli of 12/15-LO
knockout mice appear normal and that there are no
visible morphologic differences among the mesangial
cells in vivo in the two mice types.
Lipoxygenase activity and expression in MMC from
12/15-LO knockout mice versus wild-type mice
MMCs were isolated from wild-type and 12/15-LO
knockout mice and cultured in medium containing 10%
serum. We first compared basal, Ang II (0.1 umol/L),
and FCS (10%)-induced levels of cell-associated 12/15-
LO product, 12(S)-HETE, in wild-type versus 12/15-LO
knockout MMCs, by a specific radioimmunoassay that
is specific to 12(S)-HETE [16]. Figure 2A shows that
basal levels of 12(S)-HETE were significantly lower in
12/15-LO knockout cells relative to wild-type. Further-
more, while Ang II significantly increased 12(S)-HETE
levels in the wild-type MMC, it had no effect in the 12/
15-LO knockout cells (Fig. 2A). Figure 2B shows that
MMCs from 12/15-LO knockout mice also had signifi-
cantly lower FCS-induced levels of cell associated 12(S)-
HETE than MMCs from wild-type mice.
We then evaluated the level of expression of leuko-
cyte-type 12/15-LO protein in the two cell types. Serum-
depleted MMCs were stimulated with Ang II (0.1
umol/L) or FCS (10%) for 24 hours, and cell lysates
subjected to immunoblotting with a 12/15-LO–specific
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Fig. 2. Murine mesangial cells (MMCs) from 12/15-lipoxygenase (LO)
knockout (12/15-LOKO) mice have reduced 12(S)-HETE levels. Se-
rum-depleted cells were left alone or treated with angiotensin II (Ang
II) (A ) or fetal calf serum (FCS) (B ) at concentrations indicated. Cell-
associated 12(S)-HETE levels were extracted and quantitated by a
specific radioimmunoassay. Data represent mean SEM of three inde-
pendent experiments. (A) *P  0.05 vs. wild-type (WT) basal; **P 
0.001 vs. wild-type basal; #P  0.05 vs. wild-type basal; ##P  0.001
vs. wild-type Ang II. (B) *P  0.001 vs. wild-type basal; **P  0.01
vs. 12/15-LO knockout basal and wild-type FCS; #P  0.05 vs. wild-
type basal.
peptide antibody [4, 19]. Figure 3 shows that, in contrast
to wild-type cells, 12/15-LO knockout cells did not have
a72 kD 12-LO protein. Furthermore, wild-type MMCs
treated with Ang II and FCS displayed increased expres-
sion of 12/15-LO compared to basal as we have shown
earlier [16, 25]. Authentic porcine leukocyte 12-LO (Ox-
ford Biomedical Research, Inc., Oxford, MI, USA) is
shown in the far right lane. The same blot stripped and
reprobed with actin as internal control (lower panel)
indicates equal protein loading in all the lanes.
Fig. 3. Expression of 12/15-lipoxygenase (12/15-LO) protein is de-
creased in murine mesangial cells (MMCs) from 12/15-LO knockout
mice. Serum-depleted MMCs were stimulated with angiotensin II (Ang
II) (0.1 umol/L) or fetal calf serum (FCS) (10%) for 24 hours and cell
lysates analyzed for 12/15-LO expression by immunoblotting with a
peptide antibody against porcine leukocyte 12-LO (1:1000) that recog-
nizes mouse 12/15-LO. Authentic porcine leukocyte 12-LO is shown in
the far right lane. The blot was stripped and reprobed with an antibody
to actin as internal control for protein loading (lower panel).
Fig. 4. Growth pattern of mouse mesangial cells MMCs) from wild-
type (WT) versus 12/15-liopxygenase (LO) knockout (12/15-LOKO)
mice. Wild-type and 12/15-LO knockout MMCs were plated at 5000
cells per 60 mm dish and cell numbers counted daily (after trypsiniza-
tion) using a Coulter counter. Results shown are representative of data
from five MMC preparations. *P 0.05 vs. 12/15-lipoxygenase knockout
at day 5.
Cell proliferation
In order to determine whether 12/15-LO deficiency
altered MMC proliferation rates, wild-type and 12/15-
LO knockout MMCs were plated in equal numbers in
growth medium and cell numbers counted at regular
intervals. As shown in Figure 4, the MMCs from the 12/
15-LO knockout mice grew at a 20% to 25% slower rate
than those from the wild-type mice. At day 5, the reduced
growth of 12/15-LO knockout cells was statistically sig-
nificant (P  0.05, N  5).
Incorporation of [3H]-thymidine and [3H]-leucine
We next compared the rates of tritiated thymidine and
leucine incorporation into the cells to evaluate whether
the 12/15-LO knockout cells display decreased DNA and
protein syntheses, respectively. As shown in Figure 5,
MMCs from 12/15-LO knockout mice had significantly
lower basal and Ang II-induced incorporation of [3H]-
thymidine (Fig. 5A) as well as [3H]-leucine incorporation
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Fig. 5. [3H]-thymidine and [3H]-leucine incorporation are reduced in
murine mesangial cells (MMCs) from 12/15-liopxygenase (LO) knock-
out (12/15-LOKO) mice relative to wild-type (WT). Serum-starved
wild-type and 12-LO knockout MMCs were incubated overnight with
[3H]-thymidine (A) or [3H]-leucine (B) with or without angiotensin II
(Ang II) (107 M) and radioactivity in trichloroacetic acid–insoluble
protein precipitates was determined. Data represent mean SEM from
three independent experiments. *P  0.001 vs. wild-type basal; **P 
0.01 vs. 12/15-LO knockout basal and wild-type Ang II.
(Fig. 5B). Although Ang II increased these effects in
both wild-type and 12/15-LO knockout cells, the magni-
tude in the latter was markedly reduced. These results
suggest that lipoxygenase activation can play important
roles in mesangial cell growth and hypertrophy.
Superoxide production as an indicator
of oxidant stress
In order to examine key signals that may be involved in
the altered growth responses, we first tested superoxide
anion production in the two cell types as an indicator of
Fig. 6. Superoxide production is lower in 12/15-liopxygenase (LO)
knockout (12/15-LOKO) cells relative to wild-type (WT). Serum-
depleted murine mesangial cell (MMC) monolayers on 4-well chamber
slides were incubated for 30 minutes, washed, and treated with 10
	mol/L dihydroethidium (DHE) for 10 minutes. Then the cells were
washed to remove extracellular dye, mounted, and fluorescence de-
tected using a confocal microscope.
oxidant stress. Lipoxygenase activation has been shown
to lead to superoxide anion production [38]. Reactive
oxygen species (ROS) such as hydrogen peroxide and
superoxide anion have been linked to altered cellular
growth via intracellular signaling events such protein
kinase C and MAPK activation. We therefore examined
superoxide production with DHE using confocal micros-
copy. Results in Figure 6 show that basal superoxide
production was greatly reduced in 12/15-LO knockout
mice MMC relative to wild-type (wild-type 54.98 12.94
relative fluorescence intensity units versus 12/15-LO
knockout 14.44  0.48).
Activation of MAPKs
Since the growth effects of lipoxygenase products and
growth factors have been linked to the activation of
MAPKs [20, 25], we hypothesized that MAPK activa-
tion would be attenuated in the 12/15-LO knockout
cells. Serum-depleted MMCs were treated with Ang II
(0.1 umol/L) for 5, 10, and 30 minutes and with FCS
(10%) for 5 minutes and the cell lysates analyzed by
immunoblotting with phospho-specific ERK1/2 and p38
MAPK antibodies that recognize only the activated ki-
nases. As shown in Figure 7A, p38 MAPK activation
could be seen within 5 minutes after stimulation with
Ang II and FCS, especially in the wild-type cells. Basal
phospho- p38 MAPK levels were lower in the 12/15-LO
knockout MMCs compared to wild-type MMCs. Fur-
thermore, while Ang II at 5 minutes could significantly
increase p-p38 MAPK levels in the wild-type cells, it had
no effect in the 12/15-LO knockout cells (Fig. 7). The
stimulatory effects of FCS were also greatly attenuated
in the 12/15-LO knockout cells relative to wild-type (Fig.
7). The lower panel in Figure 7A shows that levels of
total p38 MAPK were not altered under these conditions.
Thus growth factor-induced p38 MAPK activation was
greatly reduced in the 12/15-LO knockout cells. This is
consistent with our earlier data showing that 12(S)-
HETE and other lipoxygenase products are potent in-
ducers of p38 MAPK activation and that this can play
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Fig. 7. Angiotensin II (Ang II) and serum-induced p38 mitogen-acti-
vated protein kinase (MAPK) activation are reduced in murine mesan-
gial cells (MMCs) derived from 12/15-lipoxygenase (LO) knockout (12/
15-LOKO) mice. Serum-depleted MMCs were stimulated with Ang II
(0.1 umol/L) for 5, 10, and 30 minutes or with 10% fetal calf serum
(FCS) for 5 minutes. Cell lysates were analyzed by immunoblotting
with the phosphospecific p38 MAPK antibody (A, upper panel). The
blots were stripped and then probed with p38 MAPK antibody (lower
panel). Bar graph (B ) shows mean  SEM data from three to five
experiments. *P  0.01 vs. wild-type basal; **P  0.001 vs. wild-type
basal; #P  0.05 vs. wild-type basal; ##P  0.001 vs. wild-type Ang II;

P  0.001 vs. wild-type FCS (N  5).
a key role in cellular hypertrophy, matrix, and inflam-
matory gene induction [20, 25, 36]. Furthermore, p38
MAPK activation was augmented in rat VSMC and car-
diac fibroblasts overexpressing 12/15-LO [20, 21].
We also examined the activation of ERK1/2 MAPK.
Figure 8A shows that, similar to p38 MAPK, basal and
FCS-induced levels of p-ERK1/2 were clearly lower in
the 12/15-LO knockout MMCs relative to wild-type.
However, Figure 8B shows that Ang II-induced levels of
p-ERK1/2 were not lower in 12/15-LO knockout MMCs.
Total ERK1/2 is seen in the lower panels of Figure 8.
Comparison of CREB phosphorylation
The significance of MAPK activation is that it can lead
to the phosphorylation and activation of key transcrip-
tion factors involved in cellular growth and hypertrophy.
Our recent study demonstrated that 12(S)-HETE could
Fig. 8. Comparison of ERK1/2 mitogen-activated protein kinase
(MAPK) activation in wild-type (WT) vs. 12/15-lipoxygenase (LO)
knockout (12/15-LOKO) cells. Experiments were performed with fetal
calf serum (FCS) and angiotensin II (Ang II) treatments as described
in Fig. 7 and cell lysates probed with an antibody to phospho-ERK1/2
(A and B, upper panels). The blots were stripped and probed with and
antibody to ERK1/2 (lower panels). Data shown are representative of
three to four experiments.
directly lead to the activation of the key transcription
factor, CREB via p38MAPK activation [20, 25, 26]. Fur-
thermore, CREB activation appeared to mediate the
expression of the key matrix protein, fibronectin [20, 25].
Hence, in the next step, we compared CREB activation
in wild-type versus 12/15-LO knockout cells. CREB tran-
scriptional activity is increased by phosphorylation at
Ser 133 mediated by MAPKs such as p38 and ERK1/2
[39, 40]. Figure 9A shows that both basal and FCS-stimu-
lated levels of phospho-CREB (p-CREB) were reduced
in the 12/15-LO knockout cells relative to wild-type cells.
Figure 9B shows that p-CREB activation could be seen
within 5 to 10 minutes after stimulation with Ang II. But
this was greatly attenuated in the 12/15-LO knockout
cells. In contrast, the same blots stripped and probed
with an antibody to CREB shows that levels of total
CREB were not altered (lower panels of Fig. 9). These
results indicate that basal, FCS, and Ang II-induced
CREB activation are lower in MMC from 12/15-LO
knockout mice.
Comparison of DNA binding activities of key
transcription factors in MMC from wild-type
and 12/15-LO knockout mice using EMSA
Since MAPK activation and CREB phosphorylation
were attenuated in 12/15-LO knockout cells, we evalu-
ated whether the DNA binding activities of the transcrip-
tion factors CREB, as well as AP-1, another key target of
MAPK, such as ERK1/2, are altered. These transcription
factors play key roles in the expression of genes required
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Fig. 9. Comparison of cyclic adenosine monophosphate (cAMP)-
responsive element binding protein (CREB) activation in wild-type (WT)
versus 12/15-lipoxygenase (LO) knockout (12/15-LOKO) cells. Experi-
ments were performed as described in Fig. 8 and cell lysates probed
with an antibody to phospho-CREB (A and B, upper panels). The blots
were stripped and probed with an antibody to CREB (lower panels).
Data shown are representative of three experiments.
for cell growth and production of matrix proteins, includ-
ing fibronectin in response to growth factors [41–43].
Serum-depleted MMCs were left untreated or stimulated
with FCS (10%) for 1 hour. Nuclear extracts were pre-
pared and analyzed for DNA binding activity by gel
shift assays using 32P-labeled oligonucleotides containing
consensus DNA binding sequences for AP-1, CREB, and
a constitutively active transcription factor, SP-1. Results
shown in Figure 10 indicate that both basal and serum-
induced DNA binding activities of AP-1 and CREB were
clearly reduced in the 12/15-LO knockout cells compared
to wild-type. However, SP-1 DNA binding activity was
similar in these nuclear extracts, indicating that the dif-
ferences in DNA binding activities were specific to AP-1
and CREB. Interestingly, there was no difference in Ang
II-induced DNA binding of AP-1 and CREB in the two
cells types (results not shown).
Comparison of the transcriptional activities
of AP-1 and CREB in wild-type versus
12/15-LO knockout cells
In order to determine whether the observed differ-
ences in DNA binding activities translate to attenuated
transcriptional activities in the 12/15-LO knockout cells,
we compared basal and FCS-stimulated AP-1 and CREB
transcriptional activities using luciferase reporter gene
assays with plasmids containing these specific transcrip-
tion factor binding sites fused to the luciferase gene (Stra-
tagene, La Jolla, CA, USA). Thus, MMCs from both
wild-type and 12/15-LO knockout mice were transiently
transfected with either pAP-1-Luc (100 ng/well) or pCRE-
Fig. 10. Activator protein-1 (AP-1) and cyclic adenosine monophos-
phate (cAMP)-responsive element binding protein (CREB) transcrip-
tion factor DNA-binding activities are reduced in murine mesangial
cells (MMCs) derived from 12/15-lipoxygenase (LO) knockout (12/15-
LOKO) mice. Nuclear extracts were prepared from control and 10%
FCS-treated cells and analyzed by gel shift assays for DNA binding
activity of the transcription factors AP-1, CREB, and SP-1 as described
in the Methods section.
Luc (200 ng/well) as described in the Methods section.
They were then stimulated with FCS (10%) for 6 hours
and luciferase activities in the cell determined. Figure
11A shows that basal AP-1 activity was significantly
lower in 12/15-LO knockout cells relative to wild-type
cells. Furthermore, while serum led to significant in-
crease in AP-1 transcriptional activity in the wild-type
cells, it was without much effect in the 12/15-LO knock-
out cells. Figure 11B shows that, in a similar fashion,
basal and FCS-induced CREB transcriptional activities
were greatly attenuated in the 12/15-LO knockout cells
relative to the wild-type cells. These results demonstrate
that the transcriptional activities of these two key nuclear
DNA binding factors, AP-1 and CREB, are greatly at-
tenuated in the MMCs from 12/15-LO knockout mice.
Relative expression of the immediate early response
(IE) gene, c-fos, and the matrix protein, fibronectin,
in wild-type and 12/15-LO knockout cells
Since the transcriptional activities of AP-1 and CREB
were attenuated in the 12/15-LO knockout cells, we next
determined whether this translates to reduced transcrip-
tion of key target genes of these transcription factors that
are relevant to cellular growth and glomerulosclerosis.
Activation of MAPKs and their target transcription fac-
tors such as AP-1 can lead to the activation of the IE
gene, c-fos, which is involved in cellular growth and is
one of the most extensively investigated members of the
IE gene family. We compared the expression of c-fos by
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Fig. 11. Activator protein-1 (AP-1) and cyclic adenosine monophos-
phate (cAMP)-responsive element binding protein (CREB) transcrip-
tional activities are reduced in murine mesangial cells (MMCs) derived
from 12/15-lipoxygenase (LO) knockout (12/15-LOKO) mice. MMCs
from wild-type or 12/15-LO knockout mice were transiently transfected
with either pAP-1-Luc plasmid (100 ng/well) (A ) or p-CRE-Luc plasmid
(200 ng/well) (B ) as described in the Methods section. They were then
stimulated with fetal calf serum (FCS) (10%) for 6 hours and luciferase
activities in the cell lysates assayed. Results shown are mean  SEM
from two experiments run in triplicate. *P  0.05 vs. wild-type basal;
**P  0.001 vs. wild-type FCS.
relative RT-PCR using 18S as an internal control in the
wild-type and 12/15-LO knockout cells. Figure 12 shows
that FCS-induced c-fos mRNA expression was evident
by 15 minutes in both wild-type and 12/15-LO knockout
cells and remained visible up to 60 minutes after stimula-
tion. However, the effects of FCS at both 15 minutes
and 30 minutes were clearly greater in the wild-type cells
relative to 12/15-LO knockout cells. Thus, the reduced
induction of IE genes such as c-fos may be one of the
mechanisms for the reduced growth effects in the 12/15-
LO knockout cells. The slightly stronger c-fos mRNA
level at 60 minutes may indicate that induction may be
delayed in 12/15-LO knockout mice but could last longer.
The implication of this is not clear and it is likely that
other IE genes are also altered.
In the next step, we compared the expression of fibro-
nectin mRNA and protein in the two cell types. Several
lines of evidence indicate that increased deposition of
extracellular matrix proteins such as fibronectin plays a
key role in the pathogenesis of glomerulosclerosis and
diabetic nephropathy. We recently showed that both
Ang II and 12(S)-HETE increased fibronectin mRNA
expression in rat mesangial cells via CREB and p38
MAPK [25]. We therefore hypothesized that fibronectin
levels may be attenuated in the 12/15-LO knockout cells.
We tested this by three methods: first, immunoblotting
with a fibronectin antibody, second, immunostaining with
a FN antibody, and finally, relative multiplex RT-PCR
for fibronectin mRNA with 18S RNA as an internal
control. The Western immunoblot in Figure 13A shows
that basal fibronectin protein levels were clearly lower in
12/15-LO knockout MMCs with the 12/15-LO knockout
cells showing little immunoreactivity. Similar results are
seen in the immunofluorescent staining data in Figure
13B which shows that the 12/15-LO knockout cells have
much less of this extracellular matrix protein compared
to the wild-type, while the Hoechst staining indicated
equal nuclei in both frames. Figure 13C shows that basal
levels of fibronectin mRNA were also lower in 12/15-
LO knockout MMCs. Furthermore, while both Ang II
and FCS could increase fibronectin mRNA expression
in the wild-type cells, they had no stimulatory effects in
the 12/15-LO knockout cells (Fig. 13C). These results
suggest that lipoxygenase activation plays a key role in
matrix protein production in rat mesangial cells. We had
noted earlier that although FCS-induced DNA binding
of AP-1 and CREB were reduced in the 12/15-LO knock-
out cells, Ang II-induced effects were not. Thus, the
attenuated responses of Ang II on fibronectin mRNA
in 12/15-LO knockout cells may involve additional mech-
anisms such as reduced CREB phosphorylation as noted
in Figure 9, or other unknown nuclear events.
Effects of stable overexpression of mouse 12/15-LO
in a MMC line
Since 12/15-LO–deficient MMC had reduced MAPK
activation and fibronectin expression, we hypothesized
that 12/15-LO overexpression may lead to increased
MAPK activation and fibronectin expression. For these
studies, we overexpressed 12/15-LO in an immortalized
MMC cell line that has been shown to retain properties
of mesangial cells [34, 37]. These cells were transfected
with either mouse 12/15-LO cDNA or control pcDNA3
vectors. Figure 14A shows one clone with high levels
of 12/15-LO relative to the mock-transfected clone
(pcDNA). Authentic 12-LO is shown in the far end.
Kim et al: Behavior of mesangial cells derived from 12/15-LO knockout mice 1711
Fig. 12. Serum-stimulated expression of the
IE gene, c-fos, is reduced in murine mesangial
cells (MMCs) from 12/15-lipoxygenase (LO)
knockout (12/15-LOKO) mice. Fetal calf se-
rum (FCS) stimulated c-fos mRNA expression
was determined by reverse transcription-poly-
merase chain reaction (RT-PCR) using mouse
c-fos gene-specific primers and 18S RNA
primers. The data shown are representative
of two similar experiments.
Fig. 13. Expression of fibronectin (FN) is reduced inmurine mesangial
cells (MMCs) derived from 12/15-lipoxygenase (LO) knockout (12/15-
LOKO) mice. (A) MMC were assayed for fibronectin expression by
immunoblotting with fibronectin (FN) antibody (1:1000). (B) Fibronec-
tin expression by immunofluorescence using the fibronectin primary
antibody (1:40) followed by incubation with rhodamine-conjugated sec-
ondary antibody (1:200). Cells were also counterstained with Hoechst
dye to detect nuclei. (C ) MMC were serum depleted for 48 hours and
then stimulated with angiotensin II (Ang II) (0.1 umol/L) or fetal calf
serum (FCS) (10%) for 24 hours. Expression of mouse fibronectin
mRNA was determined by reverse transcription-polymerase chain reac-
tion (RT-PCR) using 18S RNA as an internal control.
Figure 14B shows that levels of phospho-p38 were also
clearly higher in the 12/15-LO–overexpressing cells rela-
tive to control cells, indicating increased p38 MAPK
activity. Furthermore, Figure 14C shows that these cells
also had greater levels of fibronectin mRNA expression.
These results indicate that 12/15-LO overepxression ap-
pears to increase these key parameters associated with
renal dysfunction. This supports earlier data showing
increased glomerular 12/15-LO and fibronectin expres-
sion, as well as p38 MAPK activity in a rat model of
diabetic nephropathy [4, 46].
DISCUSSION
While several factors have been implicated in the
pathogenesis of diabetic nephropathy, the cellular and
molecular mechanisms involved are still not fully clear.
We recently demonstrated that 12/15-LO expression and
activity were enhanced in experimental diabetic ne-
phropathy in rats and correlated with expression of the
extracellular matrix protein fibronectin [4]. 12/15-LO ex-
pression and products were also increased in glucose-
and Ang II-stimulated mesangial cells [4, 25]. This path-
way also seemed to mediate the hypertrophic effects of
Ang II [25]. Furthermore, lipoxygenase products such as
12(S)-HETE could directly increase cellular hypertrophy
and fibronectin production in rat mesangial cells [25]. In
the present study, we took advantage of the availability
of the 12/15-LO knockout mice to evaluate the potential
in vivo functional significance of this pathway in mesan-
gial cells. We compared basal and growth factor-stimu-
lated oxidant stress, MAPK and transcription factor acti-
vation, cellular growth, IE gene, and matrix fibronectin
production ex vivo in MMC derived from 12/15-LO
knockout mice versus wild-type control mice. Our pres-
ent results demonstrate the significance of the 12/15-
LO pathway in leading to cellular growth and matrix
production relevant to glomerulosclerosis and diabetic
nephropathy.
The MMCs from the 12/15-LO knockout mice showed
absence of the leukocyte-type 12/15-LO. Basal levels
of the lipoxygenase product, 12(S)-HETE, were greatly
attenuated, while the stimulatory effect of Ang II on
12(S)-HETE production was abrogated. Funk [10], Chen
et al [17], Sun and Funk [27], and Johnson, Brass, and
Funk [44] have demonstrated that mice express both the
platelet- as well as leukocyte-type 12/15-LO and they
also successfully created mice in which each of these
isoforms have been specifically disrupted. Since the 12/
15-LO knockout mice in which the leukocyte 12/15-LO
has been disrupted still have the platelet isoform, it is
likely that the residual 12(S)-HETE could potentially
arise from the platelet isoform. However, there is no
specific report of the presence of a platelet 12-LO in
MMCs and more work is needed to determine the source
of the low background levels of 12(S)-HETE in the 12/
15-LO knockout cells.
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Fig. 14. Effects of stable overexpression of 12/15-lipoxygenase (12/15-
LO) in a murine mesangial cell (MMC) line. The immortalized MMC
line was transfected with either mouse 12/15-LO cDNA in the pcDNA
3.1 vector, or with empty pcDNA 3.1, and then G418-resistant colonies
isolated. (A ) A representative clone with over sixfold greater levels of
12/15-LO protein relative to the mock-transfected clone (pcDNA) (N
4). Authentic porcine leukocyte 12-LO is seen in the far right lane.
Actin levels in the same samples (lower panel) indicates equal protein
loading. (B ) A representative blot of the levels of phospho- and total
p38 mitogen-activated protein kinase (MAPK) in the two cell types.
(C ) Differential fibronectin mRNA levels in the two clones with 18S
RNA as internal control.
MMCs derived from the 12/15-LO knockout cells grew
at a slower rate and also had reduced basal and growth
factor Ang II-induced DNA and protein syntheses. This
indicates that the 12/15-LO knockout MMCs have de-
creased growth responses when compared to the MMCs
from wild-type mice. At this stage, it is not clear whether
there are differences in the number of Ang II receptors
in the two cell types. We also noted that there was de-
creased production of superoxide in the 12/15-LO knock-
out cells relative to the wild-type cells which is consistent
with data that lipoxygenase activation can lead to in-
creased superoxide and oxidant stress [38].
Earlier studies by us and others have indicated that 12/
15-LO products such as 12(S)-HETE and 13(S)-HPODE
can induce cellular growth and inflammatory gene ex-
pression via activation of MAPKs such as ERK1/2 and
p38 MAPKs [20, 25, 26, 36, 45, 46]. This was further
corroborated in the present study where we noted that
basal and growth factor-stimulated activation of p38 and
ERK1/2 MAPKs were greatly attenuated in the 12/15-
LO knockout cells relative to wild-type cells. Further-
more, basal and FCS-induced DNA binding activities of
the transcription factors AP-1 and CREB, which are key
targets of ERK1/2 and p38 MAPKs, were attenuated
in the MMC derived from lipoxygenase-deficient mice
compared to the wild-type mice. These effects were func-
tionally relevant since the transcriptional activation of
AP-1 and CREB were also attenuated. Furthermore,
levels of c-fos mRNA, a key gene controlled by AP-1,
and expression of the mRNA and protein for the ma-
trix protein fibronectin, which is controlled by CREB
[42, 43], were both greatly reduced in 12/15-LO knockout
cells. Interestingly, while Ang II-induced p38 MAPK
and CREB activation were diminished in the 12/15-LO
knockout cells, Ang II-induced ERK1/2 activation was
not significantly different. These results are again consis-
tent with the in vitro data that 12(S)-HETE leads to
fibronectin expression via activation of p38 MAPK and
CREB [20, 25]. Furthermore, p38 MAPK and CREB
activities and expression were found to be increased in
mesangial cells under high glucose conditions in vitro,
and in early diabetic glomeruli in vivo in animal models
of diabetic nephropathy [4, 46, 47]. In addition, we noted
that stable overexpression of mouse 12/15-LO cDNA in
a MMC cell line could increase p38 MAPK activity and
fibronectin mRNA expression. These results are consis-
tent with our earlier data that lipoxygenase products
such as 12(S)-HETE can directly increase fibronectin
expression and p38 MAPK activity in mesangial cells
[25] and that 12/15-LO expression is increased in a rat
model of diabetic nephropathy with parallel increases in
fibronectin expression and p38 MAPK activity [4, 46].
Recently, there has been heightened interest in 12/15-
LO due to key data from animal models implicating this
pathway in the pathogenesis of atherosclerosis, resteno-
sis, and hypertension [22, 23, 28–30, 48, 49]. Pharmaco-
logic 12/15-LO inhibitors as well as a rat 12-LO ribozyme
could block neointimal thickening in injured rat arteries
[22, 23]. Increased 12/15-LO expression was observed in
a swine model of diabetes-induced accelerated athero-
sclerosis [50]. Convincing evidence for the proathero-
genic role of 12/15-LO comes from data showing that
cross-breeding of 12/15-LO knockout mice with athero-
sclerosis prone Apo E/ or LDLR/ mice could
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greatly reduce atherosclerosis development in the latter
two mice models [28–31]. Interestingly, very recent data
indicate that VSMCs derived from these 12/15-LO knock-
out mice display attenuated responses to growth factors
relative to those from their wild-type controls [51].
In the present study, we used the 12/15-LO knockout
mice to demonstrate another pathologic role for this
enzyme in mesangial cells functions relevant to diabetic
nephropathy. Our observations of reduced growth and
matrix responses in the mesangial cells from 12/15-LO
knockout mice relative to wild-type mice suggest addi-
tional effects of this enzyme in the kidney. Clinical evi-
dence for this is obtained from data showing that urinary
12(S)-HETE excretion is markedly increased in diabetic
patients with or without microalbuminuria compared to
healthy controls [24]. Studies have also shown that lipoxy-
genase activation may play a role in renovascular hyper-
tension [48, 49, 52]. Lipoxygenase activation has been
shown to consume nitric oxide [53], which has key protec-
tive effects in the vascular and renal systems. This could
be an additional mechanism for the pathologic role of the
12/15-LO pathway in the kidney. Apart from MAPKs,
12(S)-HETE has also been shown to activate protein
kinase C [54, 55] that is known to be a major factor
underlying several diabetic complications [56]. Thus, the
12/15-LO pathway could potentially mediate the glomer-
ular changes of diabetic nephropathy through numerous
mechanistic pathways and we have been able to demon-
strate relevance by utilizing cells from 12/15-LO knock-
out mice. While we have mainly used mesangial cells in
these studies, it is highly likely that altered 12/15-LO
expression in other relevant renal cells such as podocytes
may also contribute to cellular effects mediating diabetic
nephropathy. This is supported by a recent report dem-
onstrating increased 12/15-LO expression in podocytes
in response to high glucose treatment [abstract; Adler
et al, J Am Soc Nephrol 12:380A, 2001]. In summary,
our studies show that renal 12/15-LO may play an impor-
tant role in mesangial cell growth, oxidant stress, and
extracellular matrix gene expression relevant to patho-
logic conditions such as diabetic nephropathy.
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